Open grant

Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)

From	Food and Drug Administration
Who can apply	others (see eligibility notes)
Eligibility notes	Eligible OrganizationsHigher Education InstitutionsPublic/State Controlled Institutions of Higher EducationPrivate Institutions of Higher EducationNonprofits Other Than Institutions of Higher EducationNonprofits with 501(c)(3) IRS Status (Other than…
How much	up to $600K per award
Deadline	Tue, Feb 8, 2028 (473 days left)
Category	Agriculture, Consumer Protection, Food and Nutrition
Type	Grant
Opportunity #	RFA-FD-25-017
Assistance listing	93.103
Posted	Fri, Jul 11, 2025

Open the official posting

From the notice

The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. Through the support of natural history studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specific rare disease or multiple rare diseases with similar pathophysiology, and facilitate rare disease product development.

We may have shortened this. The official posting is the record. We are not affiliated with the agency that published it.